• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Advance Lithium Corp
Amerant Bancorp Inc
Atlanticus Holdings Corporation - Common Stock
Bally's Corporation Common Stock
BlackRock Municipal Income Fund, Inc. Common Stock
Capstone Mining Corp
Champion Real Estate Investment Trust
Commercial National Financial Corp [Pa]
Container Store (The) Common Stock
D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Endeavour Mng Plc
Everspin Technologies, Inc. - Common Stock
FRP Holdings, Inc. - Common Stock
LuxUrban Hotels Inc. - Common Stock
Oregon Pacific Bncrp
Osprey Bitcoin Trust
Sonder Holdings Inc. - Class A Common Stock
Star Navigation Systems Group Ltd
University Bancorp Inc
Utah Medical Products, Inc. - Common Stock
Voya Global Advantage and Premium Opportunity Fund Common Shares of Beneficial
iRobot Corporation - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PharmaJet

< Previous 1 2 Next >
News headline image
PharmaJet® Achieves Significant Milestone with 25M Intradermal Injections Delivered for Polio Eradication
Today 10:10 EDT
From PharmaJet
Via Business Wire
News headline image
PharmaJet Highlights Vaccine Development Opportunities and Real-World Impact with Needle-Free Delivery at World Vaccine Congress Europe
October 15, 2026
From PharmaJet
Via Business Wire
News headline image
Published Review Highlights Advantages of Needle-free Intradermal Delivery Over Traditional Needle and Syringe
May 19, 2026
From PharmaJet
Via Business Wire
News headline image
PharmaJet® Tropis® Needle-free Injection System Selected to Deliver 1.4 Million Polio Vaccine Doses in Nigeria
May 07, 2026
From PharmaJet
Via Business Wire
News headline image
Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test
March 24, 2026
From PharmaJet
Via Business Wire
News headline image
PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data
January 09, 2026
From PharmaJet
Via Business Wire
News headline image
PharmaJet® Signs Distribution Agreement with EVA Pharma to Provide Needle-free Injection Systems to Support Routine Polio Immunization in Egypt
November 06, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® to Present Latest Results of its Intradermal Programs at American Society of Tropical Medicine and Hygiene Annual Meeting
November 04, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® Tropis® Needle-Free Injection System Selected for Polio Immunization Campaign in Pakistan
October 23, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference
October 21, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet®, a World Leader in Needle-Free Injection Systems, is Initiating the Development of Needle-Free Self-Injection Pens for Home Use
October 07, 2025
From PharmaJet
Via Business Wire
News headline image
CORRECTING and REPLACING Polio Vaccination Campaign Planned in Afghanistan with PharmaJet® Tropis® ID Delivery System
August 20, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® Enters into MOU Agreement with Egyptian UPA and EVA Pharma to provide Needle-free Delivery for Routine Immunization in Egypt
July 10, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine
June 19, 2025
From PharmaJet
Via Business Wire
News headline image
Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care
June 05, 2025
From PharmaJet
Via Business Wire
News headline image
Publication in Vaccine Highlights Fewer Adverse Events with PharmaJet Needle-free Intradermal Delivery compared to Needle and Syringe
May 01, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet® Presents Partner Data Demonstrating that Needle-free Delivery Boosts Immune Response of DNA and Novel Therapeutic Cancer Vaccines
April 17, 2025
From PharmaJet
Via Business Wire
News headline image
Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster Administered Intradermally with PharmaJet Tropis®
April 02, 2025
From PharmaJet
Via Business Wire
News headline image
WHO Deploys Tropis®, PharmaJet’s Needle-free Injection System in Latest Polio Eradication Campaign in Pakistan
March 13, 2025
From PharmaJet
Via Business Wire
News headline image
PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia
February 19, 2025
From PharmaJet
Via Business Wire
News headline image
CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis® Intramuscular Delivery of DNA Vaccine for Hantaviruses
December 11, 2024
From PharmaJet
Via Business Wire
News headline image
Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery
November 12, 2024
From PharmaJet
Via Business Wire
News headline image
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology Solutions
November 05, 2024
From PharmaJet
Via Business Wire
News headline image
PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery
October 24, 2024
From PharmaJet
Via Business Wire
News headline image
Improving Vaccine Performance Using PharmaJet Needle-Free Precision Delivery Technologies: World Vaccine Congress Europe Presentation
October 17, 2024
From PharmaJet
Via Business Wire
News headline image
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer
October 02, 2024
From PharmaJet
Via Business Wire
News headline image
PharmaJet and Scancell Sign Strategic Partnership Agreement for Development and Commercialization of a Needle-free DNA Vaccine for Advanced Melanoma
September 17, 2024
From PharmaJet
Via Business Wire
News headline image
PharmaJet Needle-free System Selected for WHO Polio Immunization Campaign in Somalia
June 27, 2024
From PharmaJet
Via Business Wire
News headline image
Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
April 24, 2024
From PharmaJet
Via Business Wire
News headline image
PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1
April 01, 2024
From PharmaJet
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap